These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34528303)

  • 1. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A.
    Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J
    Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan.
    Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H
    Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.
    Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J
    Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.
    Tengborn L; Baudo F; Huth-Kühne A; Knoebl P; Lévesque H; Marco P; Pellegrini F; Nemes L; Collins P;
    BJOG; 2012 Nov; 119(12):1529-37. PubMed ID: 22901076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort.
    Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P
    Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid is a common associated disorder with acquired haemophilia A.
    Abdul-Halim NA; Ng HJ
    Int J Hematol; 2021 Jan; 113(1):58-62. PubMed ID: 32949372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).
    Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A;
    Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China.
    Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R
    Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab as first-line treatment for the management of adult patients with non-severe hemophilia A and inhibitors.
    Lim MY; Nielsen B; Lee K; Kasthuri RS; Key NS; Ma AD
    J Thromb Haemost; 2014 Jun; 12(6):897-901. PubMed ID: 24702722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor eradication and treatment for acquired hemophilia A.
    Franchini M; Focosi D
    Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.
    Machado P; Raya JM; Martín T; Morabito L; Brito ML; Rodríguez-Martín JM
    Int J Hematol; 2008 Jun; 87(5):545-549. PubMed ID: 18414981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series.
    Campbell S; Mason J; Prasad R; Ambrose H; Hunt S; Tran H
    Intern Med J; 2021 Feb; 51(2):215-219. PubMed ID: 32043744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.
    D'arena G; Grandone E; Di Minno MN; Musto P; Di Minno G
    Blood Transfus; 2016 May; 14(2):255-61. PubMed ID: 26509821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acquired autoimmune haemophilia: Where is the place of rituximab in the treatment strategy? Reflection from a monocentric series of 8 patients and literature review].
    Grossin D; Broner J; Arnaud E; Goulabchand R; Gris JC
    Rev Med Interne; 2019 Sep; 40(9):574-580. PubMed ID: 30904179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose rituximab in the treatment of acquired haemophilia.
    Yao Q; Zhu X; Liu Y; Zhang F; Yuan T; Xu J; Wang X
    Hematology; 2014 Dec; 19(8):483-6. PubMed ID: 24611711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International recommendations on the diagnosis and treatment of acquired hemophilia A.
    Tiede A; Collins P; Knoebl P; Teitel J; Kessler C; Shima M; Di Minno G; d'Oiron R; Salaj P; Jiménez-Yuste V; Huth-Kühne A; Giangrande P
    Haematologica; 2020 Jul; 105(7):1791-1801. PubMed ID: 32381574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Therapy In Acquired Haemophilia - A Single Institute Experience.
    Sarah L; Prantik D; Gary B
    Ulster Med J; 2016 Sep; 85(3):187-192. PubMed ID: 27698522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
    Zeng Y; Zhou R; Duan X; Long D
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011907. PubMed ID: 27387850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.